Participants in the fourth quartile (Q4 vs. Q1) of PRSnon‐APOE exhibited a significantly increased risk of developing AD, even in the multivariable‐adjusted model (HR = 2.15, 95% CI: 1.10–4.21) (Table 3). Here, APOE is linked to Alzheimer disease.